Skip to main content

Advertisement

Log in

Antibody–drug conjugates

Breaking up is hard to do

  • News & Views
  • Published:

From Nature Chemical Biology

View current issue Submit your manuscript

A comprehensive genetic screen reveals new cellular trafficking factors and linker-dependent requirements for antibody–drug conjugate (ADC) cytotoxicity. These new insights may guide the design of optimized ADCs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Mechanisms for drug release from antibody–drug conjugates.

References

  1. Mukherjee, A. et al. Hum. Antibodies 27, 53–62 (2019).

    Article  CAS  Google Scholar 

  2. Coats, S.et al. Antibody-drug conjugates: future directions in clinical and translational strategies to improve the therapeutic index. Clin. Cancer Res. https://doi.org/10.1158/1078-0432.CCR-19-0272 (2019).

    Article  Google Scholar 

  3. Abdollahpour-Alitappeh, M. et al. J. Cell. Physiol. 234, 5628–5642 (2019).

    Article  CAS  Google Scholar 

  4. Tsui, C. K.et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-019-0342-2 (2019).

  5. Hamblett, K. J. et al. Cancer Res. 75, 5329–5340 (2015).

    Article  CAS  Google Scholar 

  6. Vaites, L. P., Paulo, J. A., Huttlin, E. L. & Harper, J. W. Mol. Cell. Biol. 38, e00392–17 (2017).

    Article  Google Scholar 

  7. Gébleux, R., Stringhini, M., Casanova, R., Soltermann, A. & Neri, D. Int. J. Cancer 140, 1670–1679 (2017).

    Article  Google Scholar 

  8. Kang, J. C. et al. Nat. Biotechnol. 37, 523–526 (2019).

    Article  CAS  Google Scholar 

  9. Chalouni, C. & Doll, S. J. Exp. Clin. Cancer Res. 37, 20 (2018).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter D. Senter.

Ethics declarations

Competing interests

The authors are employees of Seattle Genetics, a company engaged in the field of antibody–drug conjugates.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Van Epps, H.A., Senter, P.D. Breaking up is hard to do. Nat Chem Biol 15, 934–935 (2019). https://doi.org/10.1038/s41589-019-0351-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41589-019-0351-1

  • Springer Nature America, Inc.

Navigation